Valencia Technologies Announces FDA Approval of eCoin(R) Therapy to Treat Urinary Urge Incontinence

eCoin® Pivotal Trial Results Published in the Journal of Urology VALENCIA, Calif., March 2, 2022 -- (Healthcare Sales & Marketing Network) -- Valencia Technologies Corporation, a privately held company, today announced that the U.S. Food and Drug A... Devices, Urology, FDA Valencia Technologies, eCoin , neurostimulator, urinary urge incontinence
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news